+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5230946
  • Report
  • November 2020
  • Region: Global
  • 344 pages
  • GlobalData

FEATURED COMPANIES

  • 3D Biomatrix LLC
  • Abnova Corp
  • Acobiom
  • Armune BioScience Inc
  • Arquer Diagnostics Ltd
  • Atrys Health SA
Summary

The publisher's Medical Devices sector report, “Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Prostate Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Prostate Cancer Diagnostic Tests include assays of mostly antibodies released in response to a prostate cancer and cancer-causing proteins.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Prostate Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Prostate Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Prostate Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3D Biomatrix LLC
  • Abnova Corp
  • Acobiom
  • Armune BioScience Inc
  • Arquer Diagnostics Ltd
  • Atrys Health SA
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Prostate Cancer Overview

3 Products under Development
3.1 Prostate Cancer - Pipeline Products by Stage of Development
3.2 Prostate Cancer - Pipeline Products by Territory
3.3 Prostate Cancer - Pipeline Products by Regulatory Path
3.4 Prostate Cancer - Pipeline Products by Estimated Approval Date
3.5 Prostate Cancer - Ongoing Clinical Trials

4 Prostate Cancer - Pipeline Products under Development by Companies
4.1 Prostate Cancer Companies - Pipeline Products by Stage of Development
4.2 Prostate Cancer - Pipeline Products by Stage of Development

5 Prostate Cancer Companies and Product Overview

6 Prostate Cancer- Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Prostate Cancer - Pipeline Products by Stage of Development
Table 2: Prostate Cancer - Pipeline Products by Territory
Table 3: Prostate Cancer - Pipeline Products by Regulatory Path
Table 4: Prostate Cancer - Pipeline Products by Estimated Approval Date
Table 5: Prostate Cancer - Ongoing Clinical Trials
Table 6: Prostate Cancer Companies - Pipeline Products by Stage of Development
Table 7: Prostate Cancer - Pipeline Products by Stage of Development
Table 8: 3D Biomatrix LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 9: 3D Cell Assay - Metastatic Prostate Cancer - Product Status
Table 10: 3D Cell Assay - Metastatic Prostate Cancer - Product Description
Table 11: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Companion Diagnostic Test - Prostate Cancer - Product Status
Table 13: Companion Diagnostic Test - Prostate Cancer - Product Description
Table 14: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Biomarker Test - Prostate Cancer - Product Status
Table 16: Biomarker Test - Prostate Cancer - Product Description
Table 17: AccuTech LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 18: PSA Test - Product Status
Table 19: PSA Test - Product Description
Table 20: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Companion Diagnostic Assay - Prostate Cancer - Product Status
Table 22: Companion Diagnostic Assay - Prostate Cancer - Product Description
Table 23: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
Table 24: 2nd Generation Prostate Cancer Test - Product Status
Table 25: 2nd Generation Prostate Cancer Test - Product Description
Table 26: 3rd Generation Prostate Cancer Test - Product Status
Table 27: 3rd Generation Prostate Cancer Test - Product Description
Table 28: 4th Generation Prostate Cancer Test - Product Status
Table 29: 4th Generation Prostate Cancer Test - Product Description
Table 30: Urine Based Diagnostic Test - Prostate Cancer - Product Status
Table 31: Urine Based Diagnostic Test - Prostate Cancer - Product Description
Table 32: Affinimark Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Prostalent Diagnostic Test - Product Status
Table 34: Prostalent Diagnostic Test - Product Description
Table 35: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Biomarker Assay - Prostate Cancer - Product Status
Table 37: Biomarker Assay - Prostate Cancer - Product Description
Table 38: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Urine Based Non-Invasive Prostate Cancer Assay - Product Status
Table 40: Urine Based Non-Invasive Prostate Cancer Assay - Product Description
Table 41: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: NMP48 Test - Product Status
Table 43: NMP48 Test - Product Description
Table 44: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Prostate Cancer Metastatic Assay - Product Status
Table 46: Prostate Cancer Metastatic Assay - Product Description
Table 47: Andro Diagnostics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Diagnostic Test - Prostate Cancer - Product Status
Table 49: Diagnostic Test - Prostate Cancer - Product Description
Table 50: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Cchek - Prostate Cancer Recurrence Test - Product Status
Table 52: Cchek - Prostate Cancer Recurrence Test - Product Description

List of Figures
Figure 3: Prostate Cancer - Pipeline Products by Regulatory Path
Figure 1: Prostate Cancer - Pipeline Products by Stage of Development
Figure 2: Prostate Cancer - Pipeline Products by Territory
Figure 4: Prostate Cancer - Pipeline Products by Estimated Approval Date
Figure 5: Prostate Cancer - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
  • 3D Biomatrix LLC
  • A&G Pharmaceutical Inc
  • Abnova Corp
  • AccuTech LLC
  • Acobiom
  • Advanced Marker Discovery SL
  • Affinimark Technologies, Inc.
  • AIT Austrian Institute of Technology GmbH
  • Albert Ludwigs University of Freiburg
  • Alere Inc
  • Almac Diagnostic Services Ltd
  • Andro Diagnostics (Inactive)
  • Anixa Diagnostics Corporation
  • Armune BioScience Inc
  • Arno Therapeutics Inc
  • Arquer Diagnostics Ltd
  • Arrayit Corporation
  • Atrys Health SA
  • Atturos
  • Aurelium BioPharma Inc.
  • BARD1 Life Sciences Ltd
Note: Product cover images may vary from those shown
Adroll
adroll